Rapport Therapeutics Funding & Investors
Rapport Therapeutics operates as a clinical-stage biotechnology company, that discovers and develops precision medicines for neurological disorders. Rapport Therapeutics describes relationships that are defined by understanding, communication, teamwork, and trust.
rapportrx.comTotal Amount Raised: $250,000,000
Rapport Therapeutics Funding Rounds
Series B
$150,000,000
Series B Investors
Johnson & Johnson Innovation – JJDCLogos Capital ManagementCormorant Asset ManagementArch Venture PartnersThird Rock VenturesPerceptive AdvisorsSofinnova PartnersGoldman Sachs Asset ManagementT. Rowe PriceFidelity Management and Research CompanySurveyor CapitalSeries A
$100,000,000
Series A Investors
Johnson & Johnson Innovation – JJDCThird Rock VenturesArch Venture Partners
Funding info provided by Diffbot.